Bardet-Biedl syndrome: Cilia and obesity-From genes to integrative approaches;Syndrome de Bardet-Biedl: cils et obésité

Medecine/Sciences

Volumn 30, Issue 11, 2014, Pages 1034-1039

  Chennen, Kirsley ^a   Scerbo, Maria Julia ^a   Dollfus, Hélène ^a   Poch, Olivier ^a   Marion, Vincent ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONIN; MICROTUBULE ASSOCIATED PROTEIN; NERVE PROTEIN;

ADIPOSE TISSUE; ANIMAL; BARDET BIEDL SYNDROME; BIOLOGICAL MODEL; BONE MARROW; CILIARY DYSKINESIA; DEFICIENCY; DISEASE MODEL; ENDOCRINE SYSTEM; EUKARYOTIC FLAGELLUM; GENETICS; HUMAN; HYPOTHALAMUS; KNOCKOUT MOUSE; MOUSE; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RECESSIVE GENE; SIGNAL TRANSDUCTION; SYNDROME; ULTRASTRUCTURE; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; BARDET-BIEDL SYNDROME; BONE MARROW; CHAPERONINS; CILIA; CILIARY MOTILITY DISORDERS; DISEASE MODELS, ANIMAL; ENDOCRINE SYSTEM; GENES, RECESSIVE; HUMANS; HYPOTHALAMUS; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; OBESITY; SIGNAL TRANSDUCTION; SYNDROME; WEIGHT GAIN;

EID: 84911099862     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20143011018     Document Type: Article

References (69)

1. Davenport JR, Yoder BK. An incredible decade for the primary cilium: a look at a once-forgotten organelle. Am J Physiol Renal Physiol 2005; 289: F1159-F1169.
2. Basten SG, Giles RH., Functional aspects of primary cilia in signaling, cell cycle, tumorigenesis. Cilia 2013; 2: 6.
3. Yuan S, Sun Z. Expanding horizons: ciliary proteins reach beyond cilia. Annu Rev Genet 2013; 47: 353-376.
4. Satir P, Pedersen LB, Christensen ST. The primary cilium at a glance. J Cell Sci 2010; 123: 499-503.
5. Kim S, Tsiokas L. Cilia and cell cycle re-entry More than a coincidence. Cell Cycle 2011; 10: 2683-2690.
6. Goto H, Inoko A, Inagaki M. Cell cycle progression by the repression of primary cilia formation in proliferating cells. Cell Mol Life Sci 2013; 70: 3893-3905.
7. Snell WJ, Pan J, Wang Q. Cilia and flagella revealed: from flagellar assembly in Chlamydomonas to human obesity disorders. Cell 2004; 117: 693-697.
8. Ishikawa H, Marshall WF. Ciliogenesis: building the cell's antenna. Nat Rev Mol Cell Biol 2011; 12: 222-234.
9. Afzelius BA. Cilia-related diseases. J Pathol 2004; 204: 470-477.
10. Marshall WF. The cell biological basis of ciliary disease. J Cell Biol 2008; 180: 17-21.
11. Badano JL, Mitsuma N, Beales PL, Katsanis N. The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet 2006; 7: 125-148.
12. Hildebrandt F, Benzing T, Katsanis N. Ciliopathies. N Engl J Med 2011; 364: 1533-1543.
13. Mykytyn K, Nishimura DY, Searby CC, et al. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet 2002; 31: 435-438.
14. Nishimura DY, Searby CC, Carmi R, et al. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet 2001; 10: 865-874.
15. Chiang AP, Nishimura D, Searby C, et al. Comparative genomic analysis identifies an ADP-ribosylation factor-like gene as the cause of Bardet-Biedl syndrome (BBS3). Am J Hum Genet 2004; 75: 475-484.
16. Mykytyn K, Braun T, Carmi R, et al. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet 2001; 28: 188-191.
17. Li JB, Gerdes JM, Haycraft CJ, et al. Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell 2004; 117: 541-552.
18. Stone DL, Slavotinek A, Bouffard GG, et al. Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome. Nat Genet 2000; 25: 79-82.
19. Badano JL, Ansley SJ, Leitch CC, et al. Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. Am J Hum Genet 2003; 72: 650-658.
20. Ansley SJ, Badano JL, Blacque OE, et al. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 2003; 425: 628-633.
21. Nishimura DY, Swiderski RE, Searby CC, et al. Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. Am J Hum Genet 2005; 77: 1021-1033.
22. Stoetzel C, Laurier V, Davis EE, et al. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat Genet 2006; 38: 521-524.
23. Chiang AP, Beck JS, Yen HJ, et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc Natl Acad Sci USA 2006; 103: 6287-6292.
24. Stoetzel C, Muller J, Laurier V, et al. Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am J Hum Genet 2007; 80: 1-11.
25. Leitch CC, Zaghloul NA, Davis EE, et al. Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome. Nat Genet 2008; 40: 443-448.
26. Sayer JA, Otto EA, O'Toole JF, et al. The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat Genet 2006; 38: 674-681.
27. Kim SK, Shindo A, Park TJ, et al. Planar cell polarity acts through septins to control collective cell movement and ciliogenesis. Science 2010; 329: 1337-1340.
28. Otto EA, Hurd TW, Airik R, et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat Genet 2010; 42: 840-850.
29. Marion V, Stutzmann F, Gérard M, et al. Exome sequencing identifies mutations in LZTFL1, a BBSome and smoothened trafficking regulator, in a family with Bardet-Biedl syndrome with situs inversus and insertional polydactyly. J Med Genet 2012; 49: 317-321.
30. Scheidecker S, Etard C, Pierce NW, et al. Exome sequencing of Bardet-Biedl syndrome patient identifies a null mutation in the BBSome subunit BBIP1 (BBS18). J Med Genet 2014; 51: 132-136.
31. Aldahmesh MA, Li Y, Alhashem A, et al. IFT27, encoding a small GTPase component of IFT particles, is mutated in a consanguineous family with Bardet-Biedl syndrome. Hum Mol Genet 2014; 23: 3307-3315.
32. Collin GB, Marshall JD, Ikeda A, et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 2002; 31: 74-78.
33. Gupta Sen P, Prodromou NV, Chapple JP. Can faulty antennae increase adiposity? The link between cilia proteins and obesity. J Endocrinol 2009; 203: 327-336.
34. Mok CA, Heón E, Zhen M. Ciliary dysfunction and obesity. Clin Genet 2010; 77: 18-27.
35. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global burden of disease study 2013. Lancet 2014; 384: 766-781.
36. Barness LA, Opitz JM, Gilbert Barness E. Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A 2007; 143A: 3016-3034.
37. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005; 6: 221-234.
38. Bardet G. On congenital obesity syndrome with polydactyly and retinitis pigmentosa (a contribution to the study of clinical forms of hypophyseal obesity 1920). Obes Res 1995; 3: 387-399.
39. Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci 2014; 15: 367-378.
40. Broberger C, Johansen J, Johansson C, Schalling M, Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 1998; 95: 15043-15048.
41. Hahn TM, Breininger JF, Baskin DG, Schwartz MW. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1998; 1: 271-272.
42. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411: 480-484.
43. Carmi R, Elbedour K, Stone EM, Sheffield VC. Phenotypic differences among patients with Bardet-Biedl syndrome linked to three different chromosome loci. Am J Med Genet 1995; 59: 199-203.
44. Rahmouni K, Fath MA, Seo S, et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest 2008; 118: 1458-1467.
45. Seo S, Guo D-F, Bugge K, et al. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet 2009; 18: 1323-1331.
46. Berbari NF, Lewis JS, Bishop GA, Askwith CC, Mykytyn K. Bardet-Biedl syndrome proteins are required for the localization of G protein-coupled receptors to primary cilia. Proc Natl Acad Sci USA 2008; 105: 4242-4246.
47. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-884.
48. Marion V, Stoetzel C, Schlicht D, et al. Transient ciliogenesis involving Bardet-Biedl syndrome proteins is a fundamental characteristic of adipogenic differentiation. Proc Natl Acad Sci USA 2009; 106: 1820-1825.
49. Aksanov O, Green P, Birk RZ. BBS4 directly affects proliferation and differentiation of adipocytes. Cell Mol Life Sci 2014; 71: 3381-3392.
50. Berbari NF, Pasek RC, Malarkey EB, et al. Leptin resistance is a secondary consequence of the obesity in ciliopathy mutant mice. Proc Natl Acad Sci USA 2013; 110: 7796-7801.
51. Loktev AV, Jackson PK. Neuropeptide Y family receptors traffic via the Bardet-Biedl syndrome pathway to signal in neuronal primary cilia. Cell Rep 2013; 5: 1316-1329.
52. Loos RJ, Yeo GS. The bigger picture of FTO-the first GWAS-identified obesity gene. Nat Rev Endocrinol 2014; 10: 51-61.
53. Bochukova EG, Huang N, Keogh J, et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 2010; 463: 666-670.
54. Lavebratt C, Almgren M, Ekström TJ. Epigenetic regulation in obesity. Int J Obes (Lond) 2012; 36: 757-765.
55. Ortega FJ, Mercader JM, Catalán V, et al. Targeting the circulating microRNA signature of obesity. Clin Chem 2013; 59: 781-792.
56. David Brockman XC. Proteomics in the characterization of adipose dysfunction in obesity. Adipocyte 2012; 1: 25-37.
57. Xie B, Waters MJ, Schirra HJ., Investigating potential mechanisms of obesity by metabolomics. J Biomed Biotechnol 2012; 2012: 805683.
58. Li F, Jiang C, Larsen MC, et al. Lipidomics reveals a link between CYP1B1 and SCD1 in promoting obesity. J Proteome Res 2014; 13: 2679-2687.
59. Dahlman I, Elsen M, Tennagels N, et al. Functional annotation of the human fat cell secretome. Arch Physiol Biochem 2012; 118: 84-91.
60. Malpique R, Figueiredo H, Esteban Y, et al. Integrative analysis reveals novel pathways mediating the interaction between adipose tissue and pancreatic islets in obesity in rats. Diabetologia 2014; 57: 1219-1231.
61. Kurland IJ, Accili D, Burant C, et al. Application of combined omics platforms to accelerate biomedical discovery in diabesity. Ann NY Acad Sci 2013; 1287: 1-16.
62. Forsythe P, Kunze WA. Voices from within: gut microbes and the CNS. Cell Mol Life Sci 2013; 70: 55-69.
63. Stevens A, De Leonibus C, Hanson D, et al. Network analysis: a new approach to study endocrine disorders. J Mol Endocrinol 2014; 52: R79-R93.
64. Meng Q, Mäkinen VP, Luk H, Yang X. Systems biology approaches and applications in obesity, diabetes, and cardiovascular diseases. Curr Cardiovasc Risk Rep 2013; 7: 73-81.
65. Delgehyr N, Spassky N. Cil primaire, cycle cellulaire et prolifération. Med Sci (Paris) 2014; 30: 976-979.
66. Paces-Fessy M. Cils et kystes rénaux. Med Sci (Paris) 2014; 30: 1024-1033.
67. Ezan J, Montcouquiol M. Les liens multiples entre les cils et la polarité planaire cellulaire. Med Sci (Paris) 2014; 30: 1004-1010.
68. Bachmann-Gagescu R. Complexité génétique des ciliopathies et identification de nouveaux gènes. Med Sci (Paris) 2014; 30: 1011-1023.
69. Fort C, Bastin P. Élongation de l'axonème et dynamique du transport intraflagellaire. Med Sci (Paris) 2014; 30: 955-961.